Literature DB >> 24807123

Oxytocin and vasopressin modulate the social response to threat: a preclinical study.

Michael T Bowen1, Iain S McGregor1.   

Abstract

Individuals in many species increase their proximity to others in threatening situations (defensive aggregation), increasing their chance of survival and reducing the adverse psychological impact of stressors. However, the basic neurobiology of defensive aggregation is not well understood. Here we examined the role of the social neuropeptides oxytocin (OT) and vasopressin (AVP) in this response. Groups of rats were exposed to a ball of cat fur (an innate threat stimulus) in a large arena, causing prolonged periods of tight social grouping (huddling). The modulatory effects of OT and AVP on huddling were examined both alone and in conjunction with relevant antagonists. To determine specificity of treatment effects to social grouping, the effects of the same treatments were also assessed in individual rats exposed to cat fur and given the opportunity to hide. OT (0.5 mg/kg, i.p.) and AVP (0.01 mg/kg, i.p.) increased huddling in rats socially exposed to cat fur, whereas the selective V1A AVP receptor antagonist SR49059 (3 mg/kg, i.p.) decreased huddling. The effects of OT were prevented by pre-treatment with SR49059 (3 mg/kg), while those of AVP were prevented by the V1B receptor antagonist SSR149415 (30 mg/kg, i.p.). OT had no effect on huddling when groups of four rats were tested with no cat fur present whereas AVP increased huddling under these conditions. Neither OT, nor SR49059, affected hiding in individual rats exposed to cat fur. However, AVP increased hiding, an effect prevented by SSR149415 (30 mg/kg, i.p.). These results suggest that OT acts on V1A receptors to promote a social response to threat without altering the more general defensive response. Conversely, AVP appears to increase generalised anxiety via V1B receptors, which subsequently results in huddling. A hitherto unrecognised function of oxytocin is therefore to promote social affiliation during threatening situations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807123     DOI: 10.1017/S1461145714000388

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  16 in total

1.  Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice.

Authors:  Adam S Smith; Austin C Korgan; W Scott Young
Journal:  Pharmacol Res       Date:  2019-06-22       Impact factor: 7.658

2.  Oxytocin and the warm outer glow: Thermoregulatory deficits cause huddling abnormalities in oxytocin-deficient mouse pups.

Authors:  Christopher Harshaw; Joseph K Leffel; Jeffrey R Alberts
Journal:  Horm Behav       Date:  2018-01-04       Impact factor: 3.587

3.  Oxytocin in the medial prefrontal cortex attenuates anxiety: Anatomical and receptor specificity and mechanism of action.

Authors:  Sara Sabihi; Shirley M Dong; Skyler D Maurer; Caitlin Post; Benedetta Leuner
Journal:  Neuropharmacology       Date:  2017-06-24       Impact factor: 5.250

4.  Anxiety-like behavior and neuropeptide receptor expression in male and female prairie voles: The effects of stress and social buffering.

Authors:  Meghan Donovan; Yan Liu; Zuoxin Wang
Journal:  Behav Brain Res       Date:  2018-01-31       Impact factor: 3.332

5.  Number of X-chromosome genes influences social behavior and vasopressin gene expression in mice.

Authors:  Kimberly H Cox; Kayla M Quinnies; Alex Eschendroeder; Paula M Didrick; Erica A Eugster; Emilie F Rissman
Journal:  Psychoneuroendocrinology       Date:  2014-10-23       Impact factor: 4.905

6.  Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats.

Authors:  Michael T Bowen; Sebastian T Peters; Nathan Absalom; Mary Chebib; Inga D Neumann; Iain S McGregor
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

7.  Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.

Authors:  Linnet Ramos; Callum Hicks; Alex Caminer; Jack Goodwin; Iain S McGregor
Journal:  Psychopharmacology (Berl)       Date:  2015-03-15       Impact factor: 4.530

Review 8.  Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.

Authors:  Zhimin Song; H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2017-10-18       Impact factor: 8.606

9.  Oxytocin promotes functional coupling between paraventricular nucleus and both sympathetic and parasympathetic cardioregulatory nuclei.

Authors:  Jason R Yee; William M Kenkel; Jessie L Frijling; Sonam Dodhia; Kenneth G Onishi; Santiago Tovar; Maha J Saber; Gregory F Lewis; Wensheng Liu; Stephen W Porges; C Sue Carter
Journal:  Horm Behav       Date:  2016-02-04       Impact factor: 3.587

Review 10.  Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.

Authors:  Michael T Bardo; Lindsey R Hammerslag; Samantha G Malone
Journal:  Neuropharmacology       Date:  2021-04-13       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.